Dexamethasone erythrocyte encapsulated (Quince Therapeutics)

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NameDexamethasone erythrocyte encapsulated (Quince Therapeutics)
Drug Alias NameEry-DexEryDexDexa 21-P (Quince Therapeutics)Dexamethasone sodium phosphate (Quince Therapeutics)Intra-Erythrocyte Dexamethasone Sodium Phosphate (Quince Therapeutics)
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsGenetic Diseases, InbornAtaxia TelangiectasiaNervous System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[14] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEryDel SpA
China Registration ClassN/A

Develop Information

Active CompaniesQuince Therapeutics SPA
Inactive CompaniesN/A
Active IndicationsAtaxia Telangiectasia
Inactive IndicationsGenetic Diseases, InbornNervous System DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A